lymphoma

A next-generation “armored” CAR T cell therapy showed promising results in a small study of patients whose B-cell lymphomas continued…

A Phase I trial involving ten patients with relapsed or refractory classical Hodgkin lymphoma or T-cell lymphoma has achieved a…

A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific…

Researchers with City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United…